KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) EBITDA Margin (2016 - 2026)

Teladoc Health's EBITDA Margin history spans 13 years, with the latest figure at 10.51% for Q1 2026.

  • On a quarterly basis, EBITDA Margin rose 408.0% to 10.51% in Q1 2026 year-over-year; TTM through Mar 2026 was 6.73%, a 3287.0% increase, with the full-year FY2025 number at 7.77%, up 3125.0% from a year prior.
  • EBITDA Margin hit 10.51% in Q1 2026 for Teladoc Health, down from 3.93% in the prior quarter.
  • Over the last five years, EBITDA Margin for TDOC hit a ceiling of 3.69% in Q4 2023 and a floor of 1181.51% in Q1 2022.
  • Historically, EBITDA Margin has averaged 150.04% across 5 years, with a median of 10.51% in 2026.
  • Biggest five-year swings in EBITDA Margin: plummeted -113453bps in 2022 and later soared 117079bps in 2023.
  • Tracing TDOC's EBITDA Margin over 5 years: stood at 596.44% in 2022, then surged by 99bps to 3.69% in 2023, then plummeted by -110bps to 7.76% in 2024, then soared by 49bps to 3.93% in 2025, then plummeted by -167bps to 10.51% in 2026.
  • Business Quant data shows EBITDA Margin for TDOC at 10.51% in Q1 2026, 3.93% in Q4 2025, and 7.78% in Q3 2025.